Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/9356027
Conclusion of this study
Plasma total cholesterol also decreased after 4 months in the subjects receiving 19.2 micromol/day Cr. These data demonstrate that supplemental chromium had significant beneficial effects on HbA1c, glucose, insulin, and cholesterol variables in subjects with type 2 diabetes. The beneficial effects of chromium in individuals with diabetes were observed at levels higher than the upper limit of the Estimated Safe and Adequate Daily Dietary Intake.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
 Endocrine System |